Dynamic contrast-enhanced magnetic resonance imaging and pharmacokinetic models in prostate cancer

被引：0
作者：
Tobias Franiel
Bernd Hamm
Hedvig Hricak
机构：
[1] Memorial Sloan-Kettering Cancer Center,Department of Radiology
[2] Charité – Universitätsmedizin Berlin,Department of Radiology
[3] Charité,Institut für Radiologie
[4] Universitätsmedizin Berlin,undefined
来源：
European Radiology | 2011年 / 21卷
关键词：
Prostate; DCE-MRI; Pharmacokinetic parameters; Blood flow; Permeability;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Dynamic contrast-enhanced MRI enables noninvasive analysis of prostate vascularization as well as tumour angiogenesis and capillary permeability characteristics in prostate cancers. Pharmacokinetic models summarizing the complex information provided by signal intensity-time curves for a few quantitative pharmacokinetic parameters are increasingly being used in the routine clinical setting. This review consists of two parts. The first part discusses the advantages and disadvantages of the MR pulse sequences that can be used for performing DCE-MRI and also of the most widely used pharmacokinetic parameters and models and the parameters they describe. The second part outlines the range of current and potential future clinical applications of DCE-MRI and pharmacokinetic parametric maps in patients with prostate cancer, with reference to the current scientific literature on the topic. The potential clinical applications of DCE-MRI for prostate cancer include detection, localization, and staging, differentiation of recurrent cancer and estimation of the patient’s prognosis, as well as monitoring of treatment response.
引用
收藏
页码：616 / 626
页数：10
相关论文
共 304 条
[1]  
Jemal A(2009)Cancer statistics, 2009 CA Cancer J Clin 59 225-249
[2]  
Siegel R(2007)Imaging prostate cancer: a multidisciplinary perspective Radiology 243 28-53
[3]  
Ward E(1989)Prostatic carcinoma and benign prostatic hyperplasia: correlation of high-resolution MR and histopathologic findings Radiology 172 131-137
[4]  
Hao Y(2002)Patients with a history of elevated prostate-specific antigen levels and negative transrectal US-guided quadrant or sextant biopsy results: value of MR imaging Radiology 224 701-706
[5]  
Xu J(2006)Endorectal MR imaging before salvage prostatectomy: tumor localization and staging Radiology 238 176-183
[6]  
Thun MJ(2004)Endorectal MR imaging and MR spectroscopic imaging for locally recurrent prostate cancer after external beam radiation therapy: preliminary experience Radiology 233 441-448
[7]  
Hricak H(2007)Functional MR imaging of prostate cancer Radiographics 27 63-75
[8]  
Choyke PL(1993)Evaluation of the prostate and prostatic carcinoma with gadolinium-enhanced endorectal coil MR imaging Radiology 186 153-157
[9]  
Eberhardt SC(1995)The role of intravenous contrast enhancement in magnetic resonance imaging of prostatic carcinoma Clin Radiol 50 601-606
[10]  
Leibel SA(2003)Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging Radiology 229 248-254
12345678910